Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
3.0
-151.96%
20%
—
141.27%
60%
—
5 Years
Score3.0
Net Growth-151.96%
Net Trend20%
Net Income Consistency—
Rev Growth141.27%
Rev Trend60%
Revenue Consistency—
Nurix Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 17M to $ 83M and net income went from -$ 43M to -$ 264M. Revenue increased in 3 of those 5 years; net income in 1.
Nurix Therapeutics Inc currently holds a 5-year HDB Score of 3.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 26.63 | — |
1 Year2025-08-12 | $ 10.02 | 165.77% |
5 Years2021-08-12 | $ 31.63 | -15.81% |
All Time2020-07-24 | $ 19.01 | 40.08% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-07-24 |
|---|---|---|---|---|
| Price | $ 26.63 | $ 10.02 | $ 31.63 | $ 19.01 |
| Return | — | 165.77% | -15.81% | 40.08% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 71M | -$ 295M | $ 540M |
| 2025 | $ 83M | -$ 264M | $ 592M |
| 2024 | $ 54M | -$ 193M | $ 609M |
| 2023 | $ 76M | -$ 143M | $ 287M |
| 2022 | $ 38M | -$ 166M | $ 309M |
| 2021 | $ 29M | -$ 117M | $ 295M |
| IPO2020 | $ 17M | -$ 43M | $ 281M |
Explore beyond NRIX
You're looking at Nurix Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
